An inflammatory cytokine signature predicts COVID-19 severity and survival
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.05.28.20115758: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Patient information and data source: This study was reviewed and approved by the Mount Sinai Institutional Review Board.
Consent: A waiver of informed consent was obtained to query the patient electronic medical record.Randomization not detected. Blinding not detected. Power Analysis A two-sided log-rank test with an overall sample size of 674 patients (337 in each group) achieves 80% power at a 0.05 type I error to detect a hazard ratio of 2.29 when the proportion of death in the low group is 20%. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources We first validated IL-6, IL-8, and TNF-α detection by ELLA at the Mount Sinai … SciScore for 10.1101/2020.05.28.20115758: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Patient information and data source: This study was reviewed and approved by the Mount Sinai Institutional Review Board.
Consent: A waiver of informed consent was obtained to query the patient electronic medical record.Randomization not detected. Blinding not detected. Power Analysis A two-sided log-rank test with an overall sample size of 674 patients (337 in each group) achieves 80% power at a 0.05 type I error to detect a hazard ratio of 2.29 when the proportion of death in the low group is 20%. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources We first validated IL-6, IL-8, and TNF-α detection by ELLA at the Mount Sinai Human Immune Monitoring Center using plasma from multiple myeloma patients undergoing immunotherapies such as CAR-T cells and bispecific antibodies, known to elicit cytokine release storm. IL-8suggested: NoneTNF-αsuggested: NoneSoftware and Algorithms Sentences Resources The sample size calculation was conducted using PASS software. PASSsuggested: (PASS, RRID:SCR_005490)The analyses were performed using GraphPad Prism 8.4.2., GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
